These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Heat shock protein--peptide complexes as immunotherapy for human cancer. Przepiorka D; Srivastava PK Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367 [TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-peptide complex in the treatment of glioblastoma. See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695 [TBL] [Abstract][Full Text] [Related]
7. Heat shock proteins and cancer immunotherapy. Wang XY; Kaneko Y; Repasky E; Subjeck JR Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181 [TBL] [Abstract][Full Text] [Related]
8. Current ideas about applications of heat shock proteins in vaccine design and immunotherapy. Wang XY; Li Y; Yang G; Subjeck JR Int J Hyperthermia; 2005 Dec; 21(8):717-22. PubMed ID: 16338854 [TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein-peptide complex-96 for the treatment of cancer. Amato RJ Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of cancer using heat shock proteins. Manjili MH; Wang XY; Park J; Facciponte JG; Repasky EA; Subjeck JR Front Biosci; 2002 Jan; 7():d43-52. PubMed ID: 11779704 [TBL] [Abstract][Full Text] [Related]
11. Molecular chaperones and cancer immunotherapy. Wang XY; Facciponte JG; Subjeck JR Handb Exp Pharmacol; 2006; (172):305-29. PubMed ID: 16610365 [TBL] [Abstract][Full Text] [Related]
12. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy. Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391 [TBL] [Abstract][Full Text] [Related]
13. DNA vaccine for cancer immunotherapy. Yang B; Jeang J; Yang A; Wu TC; Hung CF Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927 [TBL] [Abstract][Full Text] [Related]
14. Heat shock protein vaccines: from bench to bedside. Binder RJ Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780 [TBL] [Abstract][Full Text] [Related]
15. Advances in the Development of Anticancer HSP-based Vaccines. Baldin AV; Zamyatnin AA; Bazhin AV; Xu WH; Savvateeva LV Curr Med Chem; 2019; 26(3):427-445. PubMed ID: 29376489 [TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Srivastava PK; Amato RJ Vaccine; 2001 Mar; 19(17-19):2590-7. PubMed ID: 11257397 [TBL] [Abstract][Full Text] [Related]
17. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. Blachere NE; Srivastava PK Semin Cancer Biol; 1995 Dec; 6(6):349-55. PubMed ID: 8938273 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in heat shock protein-based cancer vaccines. Wang HH; Mao CY; Teng LS; Cao J Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-based cancer immunotherapies. Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202 [TBL] [Abstract][Full Text] [Related]
20. Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy. Guo C; Subjeck JR; Wang XY Methods Mol Biol; 2018; 1709():345-357. PubMed ID: 29177671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]